CSP - Certified Specialty Pharmacist Patient Adherence and Outcomes Questions and Answers — Questions and Answers
Question 1: When measuring medication adherence using pharmacy claims data, which metric is generally preferred by quality organizations like the Pharmacy Quality Alliance (PQA) because it avoids overestimating adherence in patients who refill prescriptions early?
- Self-Reported Adherence Rate (SRA)
- Medication Possession Ratio (MPR)
- Proportion of Days Covered (PDC) (Correct answer)
- Pill Count Ratio (PCR)
Correct answer: Proportion of Days Covered (PDC)
Proportion of Days Covered (PDC) is often preferred over Medication Possession Ratio (MPR) because it caps the daily value at 1, preventing the numerator (days covered) from exceeding the denominator (days in the period) and thus avoiding an overestimation of adherence. Quality organizations like PQA and the National Committee for Quality Assurance (NCQA) use PDC for their performance measures.
Question 2: A patient with Crohn's disease on a self-injectable biologic frequently misses doses. During a follow-up call, the patient states, "I just get so anxious about giving myself the shot, and it stings. I keep putting it off." This represents which type of adherence barrier?
- System-related barrier
- Patient-related barrier
- Socioeconomic barrier
- Therapy-related barrier (Correct answer)
Correct answer: Therapy-related barrier
The patient's non-adherence is directly linked to the characteristics of the therapy itself—the pain and anxiety associated with the self-injection process. This falls under the category of therapy-related barriers, which also includes side effects and regimen complexity.
Question 3: A specialty pharmacist is counseling a patient who expresses ambivalence about starting a new oral medication for multiple sclerosis due to a fear of potential side effects. Which of the following statements best exemplifies the use of Motivational Interviewing (MI)?
- "It sounds like you're concerned about how the side effects might impact your daily life, but you're also hopeful this could prevent a relapse. Could we talk more about that balance?" (Correct answer)
- "You must take this medication as prescribed. The risk of disease progression is far worse than any potential side effects."
- "Many other patients have had the same fear, but they were fine. Let me show you the statistics on how rarely these side effects occur."
- "If you experience a side effect, just call us and we will tell you what to do. Now, let's review the injection instructions."
Correct answer: "It sounds like you're concerned about how the side effects might impact your daily life, but you're also hopeful this could prevent a relapse. Could we talk more about that balance?"
This statement uses a key MI technique called a "double-sided reflection." It acknowledges and validates the patient's concerns (the "con" of taking the medication) while also reflecting their potential motivation for taking it (the "pro"), encouraging them to explore their own ambivalence without judgment or confrontation.
Question 4: A specialty pharmacy aims to enhance its adherence program for patients taking oral medications for pulmonary arterial hypertension. Which of the following technology-based interventions is most likely to improve patient outcomes?
- Mailing a quarterly newsletter with general information about the disease state.
- Implementing a mobile application with personalized dose reminders, educational content, and a feature for tracking side effects. (Correct answer)
- Providing a link to the manufacturer's website on the prescription label.
- Requiring patients to call a hotline to confirm they have received their medication shipment each month.
Correct answer: Implementing a mobile application with personalized dose reminders, educational content, and a feature for tracking side effects.
Interactive, patient-centered technology like a comprehensive mobile app is most effective. It actively engages the patient with personalized reminders, provides easily accessible information, and allows for self-monitoring, which can improve both adherence and self-management skills, leading to better outcomes. Passive or burdensome interventions are less effective.
Question 5: A patient being treated with a direct-acting antiviral (DAA) for Hepatitis C has a Proportion of Days Covered (PDC) of 70% during their 12-week treatment course. This level of adherence is most strongly associated with which of the following outcomes?
- A guaranteed sustained virologic response (SVR).
- An increased likelihood of developing medication resistance.
- A lower overall cost of therapy due to missed doses.
- A significantly increased risk of virologic failure. (Correct answer)
Correct answer: A significantly increased risk of virologic failure.
Achieving a sustained virologic response (SVR), or a cure, with DAA therapy is highly dependent on near-perfect adherence. A PDC of 70% constitutes significant non-adherence and dramatically increases the risk of treatment failure, where the virus is not eradicated from the body. While resistance is a concern, the most direct and likely outcome is failing to achieve a cure.
Question 6: In the context of a specialty pharmacy's patient management program, which activity best demonstrates the pharmacist's role in improving patient outcomes beyond simply measuring adherence?
- Confirming the patient's shipping address and payment details before each refill.
- Proactively assessing for side effects and collaborating with the prescriber to manage them. (Correct answer)
- Generating a monthly report of the pharmacy's average Proportion of Days Covered (PDC).
- Ensuring all prescriptions are filled and shipped within the pharmacy's turnaround time goals.
Correct answer: Proactively assessing for side effects and collaborating with the prescriber to manage them.
Improving outcomes requires more than ensuring the patient has the medication. Proactive clinical management, such as assessing and managing side effects, addresses a key therapy-related barrier to adherence. This collaborative action helps the patient tolerate the therapy, remain adherent, and achieve the desired clinical goals, directly impacting their health outcome. The other options are primarily operational or administrative tasks.
CSP - Certified Specialty Pharmacist Patient Adherence and Outcomes Questions and Answers
When measuring medication adherence using pharmacy claims data, which metric is generally preferred by quality organizations like the Pharmacy Quality Alliance (PQA) because it avoids overestimating adherence in patients who refill prescriptions early?